Mastocytoma Mast Cell Tumours of the Skin
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
Mast cell tumours are cancers arising from mast cells, immune cells that normally participate in allergic and inflammatory responses. They are among the most common malignant skin tumours in dogs. Certain breeds, including Boxers, Staffordshire Bull Terriers, Boston Terriers, Pugs and others, develop them more frequently, indicating an inherited susceptibility in some populations, although no single genetic mechanism explains every case.
A mast cell tumour can appear almost anywhere on or beneath the skin and has no single characteristic appearance. It may be a soft, movable lump, a firm nodule, a hairless red swelling or a lesion that changes size from day to day. Mast cells contain histamine and other inflammatory chemicals, so manipulation can cause sudden swelling, redness, itch or bruising around the mass. In some dogs, histamine release contributes to stomach ulceration and gastrointestinal signs.
Some low-grade tumours are cured by complete local removal, while higher-grade tumours can invade locally or spread to lymph nodes, spleen, liver and other sites.
Prognosis depends on tumour grade, anatomical location, stage, growth rate and whether it can be removed completely. The number of tumours also matters less than their individual biological behaviour.
Because mast cell tumours are highly variable, a lump should never be judged benign simply because it has been present for a while or feels soft. Sampling new or changing skin masses early allows treatment decisions to be made while the tumour is still small and potentially easier to control.
The important lesson is that appearance does not predict behaviour. A small, soft or slow-growing lump can still be a mast cell tumour, while some diagnosed tumours behave very mildly.
Run their hands over the dog periodically and note the size and location of any lump so changes can be recognised. Vomiting, black stools or unexplained weakness in a dog with a known mast cell tumour may reflect systemic histamine effects and warrants prompt care.
Healthy dogs cannot be screened with a blood test that reliably predicts future mast cell tumours. Early detection depends on regular examination of the skin and prompt sampling of new or changing masses.
A veterinarian should palpate the skin and accessible lymph nodes during routine examinations. Fine-needle aspiration is quick, minimally invasive and is often the most useful first test for a suspicious mass. A lump cannot be safely classified by touch alone, and repeatedly watching an unsampled mass for growth can delay diagnosis.
Once a mast cell tumour is confirmed, staging is tailored to its risk features. This may include examination or aspiration of the draining lymph node, blood testing and imaging of abdominal organs in higher-risk cases. Histopathology after removal provides grade, margins and other information that guides further treatment.
Seek earlier assessment if a lump suddenly swells, becomes red, ulcerates or repeatedly changes size.
Screening works best when masses are sampled while small rather than relying on an annual examination alone.
Diagnosis is often straightforward with a fine-needle aspirate because mast cells have distinctive granules visible under the microscope. Biopsy or examination of the surgically removed tumour is then used to determine grade and other features associated with behaviour. Cytology and histopathology, rather than visual appearance alone, are what allow risk to be assessed properly.
Surgical removal is the main treatment for most localised mast cell tumours. The surgeon plans margins according to tumour size, location and expected biological behaviour. Histopathology determines whether the tumour was completely removed and assigns grade and other prognostic features. Additional surgery may be recommended when important tumour cells remain at the margin.
Radiation therapy can provide excellent local control when a tumour cannot be completely removed or further surgery would be difficult. Chemotherapy or targeted drugs may be considered for high-grade tumours, metastatic disease or tumours carrying molecular changes that make targeted treatment appropriate.
Medications such as antihistamines and acid-suppressing drugs are often used around treatment when histamine release is a concern. These medicines reduce complications but do not treat the cancer itself.
Follow-up includes examination of the surgical site, lymph nodes and the rest of the skin because some dogs develop additional mast cell tumours later. New lumps should be aspirated rather than assumed to be the same grade as a previous tumour.
Many low-grade mast cell tumours are cured by appropriate surgery. Higher-grade disease has a more guarded prognosis and may require multimodal treatment. Early diagnosis improves options because a small tumour is generally easier to remove with adequate margins than one allowed to grow over a large or anatomically difficult area.
Border terrier
Open dog breed description, care requirements and conditions
Boston terrier
Open dog breed description, care requirements and conditions
Boxer
Open dog breed description, care requirements and conditions
Bull terrier
Open dog breed description, care requirements and conditions
Pug
Open dog breed description, care requirements and conditions
Staffordshire bull terrier
Open dog breed description, care requirements and conditions
Weimaraner
Open dog breed description, care requirements and conditions